On Tuesday, EnteroMedics Inc (NASDAQ:ETRM)’s shares enhanced 16.09%, and closed at $1.01, as the EnteroMedics Inc. the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, recently declared that 15 centers have been certified and 19 physicians were trained in implanting and administering vBloc Therapy as of the end of the first quarter of 2015, supporting the corporation’s aim of training 20-25 vBloc Therapy centers and physicians by the end of 2015.
EnteroMedics’ bariatric center selection, training and certification process follows a defined protocol that comprises rigorous center qualification criteria and didactic and surgical training. Once the center criteria are met, the Corporation’s field staff trains the surgeon and staff on vBloc Therapy, theory of operation, and program implementation. This is followed by procedure and system operation training and one or two supervised surgeries, after which the surgeon is certified.
EnteroMedics Inc., a medical device corporation, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
Cheetah Mobile Inc (ADR) (NYSE:CMCM), inclined 12.49%, and closed at $23.95, as the Cheetah Mobile Inc. a leading mobile Internet corporation that provides mission critical applications to assist make the Internet and mobile experience speedier, simpler, and safer for users worldwide, declared that it has signed a commercial contract with Nanigans, Inc. (“Nanigans”), a leading worldwide provider of social and mobile advertising software and pioneer in advertising automation software.
The commercial contract comes in conjunction with Cheetah Mobile’s recent planned investment as the lead investor in Nanigans US$24 million Series B financing.
Following the commercial contract between Cheetah Mobile and Nanigans, Cheetah Mobile will be the exclusive partner of Nanigans in the Greater China region to manage campaigns for advertisers using Nanigans advertising automation software.
Cheetah Mobile Inc. operates a platform that offer mission critical applications for its users and global content distribution channels for its business partners in the People’s Republic of China. The corporations mission critical applications optimize Internet and mobile system performance and provide real time protection against known and unknown security threats.
At the end of Tuesday’s trade, BIND Therapeutics Inc (NASDAQ:BIND), surged 11.46%, and closed at $6.32, after that BIND Therapeutics, Inc. a clinical-stage nanomedicine platform corporation developing targeted and programmable therapeutics called Accurins™, recently declared an extension of the terms of its global partnershipwith Pfizer Inc. to create Accurins that optimize the therapeutic potential of two molecularly targeted oncology drugs in Pfizer’s pipeline.
The partnershipwas originally established in April 2013 and the timeline for Pfizer to exercise its option to attain the exclusive license for the first program continues to be September 2015. Both companies agreed to an extension of the timeline for the second program through March 2016.
BIND Therapeutics, Inc., a clinical-stage nanomedicine platform corporation, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specific pharmaceutical characteristics intended to target tumors at tissue, cellular, and molecular levels and to result in superior patient outcomes by enhancing the concentration and duration of therapeutic payloads at disease sites while reducing exposure to healthy tissue.
Fidelity & Guaranty Life (NYSE:FGL), gained 11.26%, and closed at $23.13, as the HRG Group, Inc. declared that it is exploring planned alternatives for Fidelity & Guaranty Life counting a potential sale of FGL, or of all or part of HRG’s 80.6% interest in FGL.
HRG noted that there can be no assurance that the exploration of planned alternatives will result in a transaction or that any transaction, if pursued, will be consummated. The exploration of planned alternatives may be terminated at any time and without notice.
HRG attaind 100% of FGL in April 2011. In December 2013, FGL successfully accomplished an IPO of 19.3% of its interest at that time. HRG did not sell any FGL shares as part of that offering.
Foster’s Group Limited (Foster) is an Australia-based corporation engaged in production and marketing of alcoholic beverages. The Corporation operates in five segments: Carlton and United Breweries (CUB), Australia & New Zealand Wine (ANZ Wine), Europe, Middle East and Africa (EMEA Wine), Americas Wine and Asia Wine. Foster’s beer portfolio comprises brands, such as VB, Carlton Draught, Crown Lager and Pure Blonde.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
